Oncology Institute, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
—
Last report2 of 6 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+28.46%
vs ±13.5% implied · ×2.11
shaded = implied · ▲▼ = realized
Starling Oncology has 2 disclosed suppliers and 6 disclosed customers in SEC filings.
Starling Oncology, Inc.
6.55
SentenceFinally, while we were impacted by the Change Healthcare cyberattack in February 2024, which caused disruptions to healthcare companies across the US, our team actively collaborated with our practice management vendor to swiftly establish alternative channels for transmitting claims to payors.
TOI 10-Kaccession 0001799191-26-000007
SentenceAdditionally, the Company pays a management fee to Helios on a periodic basis for certain shared services.
TOI 10-Kaccession 0001799191-26-000007
SentenceSome of the biggest and most respected names in healthcare contract with the TOI PCs to provide oncology care to their members, including Anthem, CareMore Health, Heritage Provider Network and Optum Care.
SentenceSome of the biggest and most respected names in healthcare contract with the TOI PCs to provide oncology care to their members, including Anthem, CareMore Health, Heritage Provider Network and Optum Care.
TOI 10-Kaccession 0001799191-26-000007
SentenceSome of the biggest and most respected names in healthcare contract with the TOI PCs to provide oncology care to their members, including Anthem, CareMore Health, Heritage Provider Network and Optum Care.
TOI 10-Kaccession 0001799191-26-000007
SentenceThe TOI PCs receive a significant portion of revenue directly from Medicare, which accounted for approximately 14% of our Patient Services revenue in 2025.
TOI 10-Kaccession 0001799191-26-000007
SentenceWe conduct some clinical trials in contract with TOI Clinical Research, LLC ("TCR") .
TOI 10-Kaccession 0001799191-26-000007
Linked news
NewsExpected move
No implied move.